25/100B40.420
USD
-0.24
(-0.59%)
Market Open
Last updated: · Delayed 15 min
Roivant Sciences EPS (earnings per share) 2019–2026What is EPS (earnings per share)? EPS (earnings per share) is a company's net income divided by its number of shares: the profit that belongs to each share over a period.
Roivant Sciences's diluted EPS in Q2 FY2026, the three months to 30 September 2026, was -0.27 USD, against a loss of 0.17 USD on the same quarter a year before. Roivant Sciences's diluted earnings per share in fiscal year 2025 were -0.43 USD, against a loss of 0.24 USD on the year before.
Last updated 10 Nov 2026 · Next report 5 Feb 2027
EPS
Growth
| Fiscal year | Period ending | EPS | Growth | EPS (basic) |
|---|---|---|---|---|
| TTM | 30 Sept 2026 | -0.54 | — | -0.48 |
| FY2025 | 31 Mar 2026 | -0.43 | — | -0.43 |
| FY2024 | 31 Mar 2025 | -0.24 | -104.59% | -0.24 |
| FY2023 | 31 Mar 2024 | 5.23 | — | 5.55 |
| FY2022 | 31 Mar 2023 | -1.42 | — | -1.42 |
| FY2021 | 31 Mar 2022 | -1.26 | — | -1.26 |
| FY2020 | 31 Mar 2021 | -1.18 | -167.43% | -1.18 |
| FY2019 | 31 Mar 2020 | 1.75 | — | 1.75 |
| Quarter | Period ending | EPS | Growth on a year before | EPS (basic) |
|---|---|---|---|---|
| Q2 FY2026 | 30 Sept 2026 | -0.27 | — | -0.27 |
| Q1 FY2026 | 30 Jun 2026 | -0.26 | — | -0.26 |
| Q4 FY2025 | 31 Mar 2026 | 0.37 | — | 0.43 |
| Q3 FY2025 | 31 Dec 2025 | -0.38 | -265.22% | -0.38 |
| Q2 FY2025 | 30 Sept 2025 | -0.17 | — | -0.17 |
| Q1 FY2025 | 30 Jun 2025 | -0.33 | -375.00% | -0.33 |
| Q4 FY2024 | 31 Mar 2025 | -0.29 | — | -0.29 |
| Q3 FY2024 | 31 Dec 2024 | 0.23 | -96.19% | 0.23 |
| Q2 FY2024 | 17 Sept 2024 | -0.31 | — | -0.31 |
| Q1 FY2024 | 30 Jun 2024 | 0.12 | — | 0.13 |
| Q4 FY2023 | 31 Mar 2024 | -0.19 | — | -0.19 |
| Q3 FY2023 | 31 Dec 2023 | 6.03 | — | 6.37 |
| Q2 FY2023 | 30 Sept 2023 | -0.40 | — | -0.40 |
| Q1 FY2023 | 30 Jun 2023 | -0.38 | — | -0.38 |
| Q4 FY2022 | 31 Mar 2023 | -0.05 | — | -0.05 |
| Q3 FY2022 | 31 Dec 2022 | -0.49 | — | -0.49 |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Revenue,Net income,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement
Common questions about Roivant Sciences's EPS
Source: Financial Modeling Prep